Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: Results from the dutch arthritis and biologicals in children register

Additional Metadata
Keywords	Adalimumab, Anti-tumour necrosis factor, Biologic therapy, Etanercept, Oligoarticular juvenile idiopathic arthritis, Response
Persistent URL	doi.org/10.1093/rheumatology/kes373, hdl.handle.net/1765/65403
Journal	Rheumatology (Oxford, England)
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Anink, J, Otten, M.H, Prince, F.H.M, Hoppenreijs, E.P.A.H, Wulffraat, N.M, Swart, J.F, … van Suijlekom-Smit, L.W.A. (2013). Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: Results from the dutch arthritis and biologicals in children register. Rheumatology (Oxford, England), 52(4), 712–717. doi:10.1093/rheumatology/kes373

Publication